Lab-Grown Blood Given to Humans in World-First Trial Aimed at Combating Rare Disorders

November 7, 2022

(CNBC) – Blood grown in a laboratory has been transfused into humans for the first time in a landmark clinical trial that U.K. researchers say could significantly improve treatment for people with blood disorders and rare blood types. Two patients in the U.K. received tiny doses — equivalent to a few teaspoons — of the lab-grown blood in the first stage of a wider trial designed to see how it behaves inside the body. (Read More)